As of Aug 28
| +0.32 / +5.05%|
The 3 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 18.75, with a high estimate of 25.00 and a low estimate of 11.50. The median estimate represents a +181.53% increase from the last price of 6.66.
The current consensus among 3 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.